BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3615989)

  • 1. New approaches in risk assessment for carcinogens.
    Perera F
    Risk Anal; 1986 Jun; 6(2):195-201. PubMed ID: 3615989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagen, carcinogen and tumor promoter in daily life.
    Sugimura T
    J UOEH; 1989 Mar; 11 Suppl():346-52. PubMed ID: 2664948
    [No Abstract]   [Full Text] [Related]  

  • 3. [The mutagenic and carcinogenic activity of chemical compounds].
    Rakitskiĭ VN; Turusov VS
    Vestn Ross Akad Med Nauk; 2005; (3):7-9. PubMed ID: 15852703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unique role of rodents in the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra.
    Barbin A
    Mutat Res; 2000 Apr; 462(2-3):55-69. PubMed ID: 10767618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs.
    Bartsch H; Tomatis L
    Environ Health Perspect; 1983 Jan; 47():305-17. PubMed ID: 6337827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The early detection of frameshift mutations induced by a food-borne carcinogen in rats: a new tool for molecular epidemiology.
    Burnouf DY; Fuchs RP
    Mutat Res; 2000 Apr; 462(2-3):281-91. PubMed ID: 10767638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A view of the relation between carcinogenesis and mutagenesis.
    Lijinsky W
    Environ Mol Mutagen; 1989; 14 Suppl 16():78-84. PubMed ID: 2659336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis and carcinogenesis: endogenous and exogenous factors.
    Ames BN
    Environ Mol Mutagen; 1989; 14 Suppl 16():66-77. PubMed ID: 2659334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between systemic toxicity and genotoxicity: relevance to human cancer risk.
    Rosenkranz HS
    Mutat Res; 2003 Aug; 529(1-2):117-27. PubMed ID: 12943925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term tests for mutagenesis and carcinogenesis in drug toxicology: how to test and when to test is the question.
    De La Iglesia FA; Lake RS; Fitzgerald JE
    Drug Metab Rev; 1980; 11(1):103-46. PubMed ID: 6448737
    [No Abstract]   [Full Text] [Related]  

  • 16. Contributions from molecular/biochemical approaches in epidemiology to cancer risk assessment and prevention.
    Lohman PH; Morolli B; Darroudi F; Natarajan AT; Gossen JA; Venema J; Mullenders LH; Vogel EW; Vrieling H; van Zeeland AA
    Environ Health Perspect; 1992 Nov; 98():155-65. PubMed ID: 1486845
    [No Abstract]   [Full Text] [Related]  

  • 17. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
    Bartsch H; Malaveille C
    Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk evaluation of carcinogens and their threshold levels, part III].
    Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):911-20. PubMed ID: 16937321
    [No Abstract]   [Full Text] [Related]  

  • 19. [Short-term tests in the system of assessment of human carcinogens].
    Belitskiĭ GA; Khudoleĭ VV
    Vopr Onkol; 1986; 32(4):3-11. PubMed ID: 3518237
    [No Abstract]   [Full Text] [Related]  

  • 20. Genotoxicity and carcinogenicity of fluorocarbons: assessment by short-term in vitro tests and chronic exposure in rats.
    Longstaff E; Robinson M; Bradbrook C; Styles JA; Purchase IF
    Toxicol Appl Pharmacol; 1984 Jan; 72(1):15-31. PubMed ID: 6710481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.